Haemophilus influenzae is a pathogen that causes invasive bacterial infections in humans. The highest prevalence lies in both young children and adults. Generally, there are no vaccines available that target all the strains of Haemophilus influenzae. Hence, the purpose of this research is to employ bioinformatics and immunoinformatics approaches to design a Multi-Epitope Vaccine candidate employing the pathogenic cell division protein FtsN that specifically combat all the Haemophilus influenzae strains. The current research focuses on developing subunit vaccine in contrast to vaccines generated from the entire pathogen. This will be accomplished by combining multiple bioinformatics and immunoinformatics approaches. As a result, prospective T cells (helper T lymphocyte and cytotoxic T lymphocytes) and B cells epitopes were investigated. The human leukocyte antigen allele having strong associations with the antigenic and overlapping epitopes were chosen, with 70% of the total coverage of the world population. To construct a linked vaccine design, multiple linkers were used. To increase the immunogenic profile, an adjuvant was linked using EAAAK linker. The final vaccine construct with 149 amino acids was obtained after adjuvants and linkers were added. The developed Multi-Epitope Vaccine has a high antigenicity as well as viable physiochemical features. The 3D conformation was modeled and undergoes refinement and validation using bioinformatics methods. Furthermore, protein–protein molecular docking analysis was performed to predict the effective binding poses of Multi-Epitope Vaccine with the Toll-like receptor 4 protein. Besides, vaccine underwent the codon translational optimization and computational cloning to verify the reliability and proper Multi-Epitope Vaccine expression. In addition, it is necessary to conduct experiments and research in the laboratory to demonstrate that the vaccine that has been developed is immunogenic and protective.
21 February 2022 in Molecular and Clinical Oncology
Cancer is a major health issue worldwide. cfDNA integrity has been reported as a potential diagnostic molecular marker for different types of cancer, identifying the importance of liquid biopsy. The aim of this review was to evaluate the prognostic and diagnostic performance of Arthrobacter luteus (ALU) repeat in tumor. Following a thorough review of the literature published from January, 2000 to September 2021, 36 studies were included. All of the study descriptions were analyzed. According to several studies, there were increased concentrations of ALU repetitive elements in cancer patients, while these concentrations were decreased in control, benign, different cancer stage, and other diseases. The total ALU (115 and 247) sequence levels are potential biomarkers for the purpose of investigations and cancer prognosis.
Root-knot nematodes significantly reduce cucumber yields, prompting the development of a genetic engineering strategy as an alternative to chemical nematicides. In this study, the maize CCII gene was cloned into the pHT1469 shuttle vector and transformed into the Bacillus subtilis expression system to produce a cystatin that interferes with nematode digestive proteins. The full-length CCII cDNA sequence was optimized for overexpression in B. subtilis, driven by the Pgrac promoter, resulting in a protein of 134 amino acids with a deduced molecular mass of 15.01 kDa. After optimization, the relative adaptiveness in the heterologous B. subtilis system improved by 6.72% compared to non-optimized codons. Purification results using immobilized metal affinity chromatography (IMAC) indicated that the third fraction exhibited the highest inhibition activity, and the purified cystatin was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to be approximately 15 kDa. Treatments with nematode juveniles showed the highest mortality percentages at 30% and 40% concentrations of purified cystatin isolated from both competent and wild B. subtilis cells, yielding mortality rates of 65%, 73.7%, 75.3%, and 89% respectively after 72 h. Furthermore, the recombinant cystatin isolated from the first B. subtilis (wild) strain had a greater impact on juvenile mortality than the second strain. This study aimed to clone and express corn cystatin in heterologous B. subtilis and evaluate its effectiveness in reducing nematode populations, exploring its potential as a biocontrol agent.